Related Experiment Video
Updated: May 22, 2026
09:06
MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
MicroRNAs: relevant tools for a colorectal surgeon?
Oliver Peacock1, Andrew C Lee, Michael Larvin
1Division of Surgery, School of Graduate Entry Medicine & Health, University of Nottingham, Royal Derby Hospital, Uttoxeter Road, Derby, DE22 3DT, UK. oliver.peacock@nhs.net
World Journal of Surgery
|April 25, 2012
Summary
MicroRNAs (miRNAs) show promise as noninvasive biomarkers for colorectal cancer detection. Analyzing miRNA profiles in stool and plasma can aid in early diagnosis and treatment strategies for this common malignancy.
Area of Science:
- Oncology
- Molecular Biology
- Biomarker Discovery
Background:
- Colorectal cancer is a leading cause of cancer death globally, often diagnosed late.
- Early detection is crucial for preventing mortality, but current screening methods have limitations.
- There is a need for sensitive and specific noninvasive biomarkers for colorectal cancer diagnosis, staging, and treatment selection.
Purpose of the Study:
- To review the role of microRNAs (miRNAs) in colorectal cancer.
- To highlight the diagnostic, prognostic, and therapeutic potential of miRNAs.
- To explore the feasibility of using miRNAs as noninvasive biomarkers.
Main Methods:
- Review of existing literature on microRNAs in colorectal cancer.
- Analysis of miRNA expression patterns in tumor and normal tissues.
- Assessment of miRNA stability and detectability in biological samples like stool and plasma.
Main Results:
- MicroRNAs are key regulators of gene expression involved in cellular processes relevant to cancer.
- Aberrant miRNA expression is a hallmark of colorectal cancer cells.
- Colorectal cancer-associated miRNAs are stable and detectable in stool and plasma samples, making them accessible for analysis.
Conclusions:
- MicroRNA profiling in colorectal cancer offers potential for accurate diagnosis and prognosis.
- Stable miRNAs in stool and plasma represent promising noninvasive biomarkers for colorectal cancer screening.
- Further research into miRNA-based diagnostics and therapeutics could significantly improve patient outcomes.
